BNTC
Benitec Biopharma·NASDAQ
--
--(--)
--
--(--)
1.95 / 10
Underperform
Technical rating is Underperform with a 1.95/10 score. All three signals—Long Lower Shadow, Long Upper Shadow, and MACD Death Cross—are bearish, showing negative returns and low win rates. Momentum is weak, suggesting further downside risk.
Analysis Checks(0/3)
Long Lower Shadow
Score1.94/10
Win Rate43.75%
Hist. Signals64
Avg Return-0.24%
Score1.94/10
Win Rate43.75%
Hist. Signals64
Avg Return-0.24%
MACD Death Cross
Score1/10
Win Rate12.50%
Hist. Signals8
Avg Return-5.02%
Score1/10
Win Rate12.50%
Hist. Signals8
Avg Return-5.02%
Long Upper Shadow
Score2.9/10
Win Rate48.78%
Hist. Signals41
Avg Return0.17%
Score2.9/10
Win Rate48.78%
Hist. Signals41
Avg Return0.17%
Long Lower Shadow
Score1.94/10
Win Rate43.75%
Hist. Signals64
Avg Return-0.24%
Score1.94/10
Win Rate43.75%
Hist. Signals64
Avg Return-0.24%
Long Upper Shadow
Score2.9/10
Win Rate48.78%
Hist. Signals41
Avg Return0.17%
Score2.9/10
Win Rate48.78%
Hist. Signals41
Avg Return0.17%
MACD Death Cross
Score1/10
Win Rate12.50%
Hist. Signals8
Avg Return-5.02%
Score1/10
Win Rate12.50%
Hist. Signals8
Avg Return-5.02%
What is the current technical signals for BNTC?
- BNTC presents a Underperform setup with a Technical Score of 1.95/10. Key technical indicators highlight an RSI of 46.39 and a MACD of -0.17, with the trend anchored by the 50-Day SMA at 11.46. Traders should monitor key support at 10.22 and resistance at 10.98.
